| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 05/26/2006 | WO2006054945A1 Methods for assessing the predisposition or susceptibility to copd |
| 05/26/2006 | WO2005049787A3 Compositions and methods for in vitro sorting of molecular and cellular libraries |
| 05/26/2006 | WO2005047472A3 Increasing seed threonine content through alteration of threonine aldolase activity |
| 05/26/2006 | WO2005030933A3 Bone morphogenetic protein (bmp)-7 based diagnosis and treatment of cancer |
| 05/26/2006 | WO2005028621A3 Assays with primary cells |
| 05/26/2006 | WO2004113498A3 Rna interferases and methods of use thereof |
| 05/26/2006 | WO2004108897A3 Sirna libraries |
| 05/25/2006 | US20060108229 Large volume ex vivo electroporation method |
| 05/24/2006 | EP1658364A2 Tubulin regulatory elements for use in plants |
| 05/24/2006 | EP1658303A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 05/24/2006 | EP1497409B1 Growth medium for microorganisms comprising the biomass of methanotrophic and heterotrophic bacteria |
| 05/24/2006 | CN1777683A Method to identifying genetic traits in animals |
| 05/24/2006 | CN1777680A Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells |
| 05/24/2006 | CN1777670A New strains of bifidobacterium having the ability to produce glutamine |
| 05/24/2006 | CN1777437A Biologically active native biomatrix composition |
| 05/23/2006 | US7049076 Method for assaying protein—protein interaction |
| 05/23/2006 | US7048930 Expression of core-glycosylated HCV envelope proteins in yeast |
| 05/18/2006 | WO2006051172A1 Method for testing a compound for a therapeutic effect and a diagnostic method |
| 05/18/2006 | WO2005033280A8 Hiv-dependent expression constructs and uses therefor |
| 05/18/2006 | WO2005019422A3 Silencing of tgf-beta receptor type ii expression by sirna |
| 05/18/2006 | WO2005012497A3 Translocation tagging |
| 05/18/2006 | WO2004074445A3 Model for studying the role of genes in tumor resistance to chemotherapy |
| 05/18/2006 | WO2004072238A3 Terminal-phosphate-labeled nucleotides with new linkers |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060105380 Synthesizing cDNA via primers, mixing with second sample, transcribing, then detecting |
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP1656443A2 Solid phase cell lysis and capture platform |
| 05/17/2006 | EP1656025A2 A stable liquid probiotic composition, preparation and applications thereof |
| 05/17/2006 | EP1656012A2 Plants resistant to cytoplasm-feeding parasites |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | CN1774511A Fragmentation-based methods and systems for sequence variation detection and discovery |
| 05/17/2006 | CN1774499A A device. |
| 05/11/2006 | WO2005056764A3 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 05/11/2006 | WO2005056758A3 Methods and compositions for genetically detecting improved milk production traits in cattle |
| 05/11/2006 | WO2005054439A3 Small interfering rna (sirna)-mediated heritable gene manipulation in plants |
| 05/11/2006 | WO2005047461A3 Polypeptide display libraries and methods of making and using thereof |
| 05/11/2006 | WO2005033272A3 In vivo synthesis of connective tissues |
| 05/11/2006 | WO2005019414A3 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 05/11/2006 | WO2005007797A3 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 05/11/2006 | WO2004033646A3 Process for the biological production of 1,3-propanediol with high yield |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060100134 fusion proteins; drug delivery |
| 05/11/2006 | US20060099209 prostate and breast carcinoma; used for diagnosis to identify individuals with the high probability of having a malignant disease |
| 05/10/2006 | EP1654537A2 Tssk4: a human testis specific serine/threonine kinase |
| 05/10/2006 | EP1654536A2 Primary rat hepatocyte toxicity modeling |
| 05/10/2006 | EP1654385A2 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment |
| 05/10/2006 | EP1654379A2 Methods and compositions for enhanced protein expression and purification |
| 05/10/2006 | EP1654378A2 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 05/10/2006 | EP1654348A2 Bacterial strains, compositions including same and probiotic use thereof |
| 05/10/2006 | EP1654239A2 Peptide deformylase inhibitors |
| 05/10/2006 | EP1290136B1 Probiotics for pet food applications |
| 05/10/2006 | CN1771334A Method for determining susceptibility of tumor to treatment with anti-neoplastic agent |
| 05/10/2006 | CN1771050A Macrocyclic hepatitis c serine protease inhibitors |
| 05/10/2006 | CN1255551C Method of detection of nucleic acids with a specific sequence composition |
| 05/09/2006 | US7043371 Method for search based character optimization |
| 05/09/2006 | US7041869 Genetically engineered rodents comprising expression constructs coding luciferase reporter genes for use as tool in identifying cancer preventatives; antitumor agents |
| 05/09/2006 | US7041449 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging |
| 05/09/2006 | CA2093950C Subtilisin-like protease from aspergillus niger |
| 05/04/2006 | WO2006030071A3 Methods for the utilization of novel target genes related to immune-mediated diseases |
| 05/04/2006 | WO2005033285A3 GENE MODULATION BY RB2/p130 EXPRESSION |
| 05/04/2006 | WO2005021719A3 Libraries of recombinant chimeric proteins |
| 05/04/2006 | WO2005021709A8 Cln101 antibodies |
| 05/04/2006 | WO2005007805A3 ANTISENSE ANTIVIRAL AGENT AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
| 05/04/2006 | WO2005001035A3 Ladder copolymers |
| 05/04/2006 | US20060094677 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics |
| 05/04/2006 | US20060093613 Soluble T cell receptor |
| 05/03/2006 | EP1651752A2 Methods of inhibiting cancer growth by binding to nuclear receptors |
| 05/03/2006 | EP1651751A2 Engineered proteases for affinity purification and processing of fusion proteins |
| 05/03/2006 | EP1651750A2 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 05/03/2006 | EP1651660A2 Methods and compositions for targeted cleavage and recombination |
| 05/03/2006 | EP1651259A2 Methods and compositions for producing antigenic responses |
| 05/03/2006 | EP1651252A2 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 05/03/2006 | EP1651251A2 Methods for treating diabetes and related disorders using pde10a inhibitors |
| 05/03/2006 | EP1651207A2 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors |
| 05/03/2006 | EP1576150A4 Methods and compositions for increasing the efficacy of biologically-active ingredients |
| 05/03/2006 | EP1490486A4 Method of identifying genes controlling diferentiation |
| 05/03/2006 | CN1768265A Methods and compositions for purification of nucleic acid from a host cell |
| 05/03/2006 | CN1768139A Regulation of gene expression by DNA interference |
| 05/03/2006 | CN1768133A Use of ISLET 1 as a marker for isolating or generating stem cells |
| 05/03/2006 | CN1768075A Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 05/03/2006 | CN1767860A Methods and compositions for administering therapeutic and diagnostic agents |
| 05/03/2006 | CN1766111A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 05/02/2006 | US7039261 Etalon based compact dispersion module |
| 05/02/2006 | US7037720 Neuroepithelial stem cells and glial-restricted intermediate precursors |
| 04/27/2006 | WO2005059110A3 Methods and materials for canine breed identification |
| 04/27/2006 | WO2005033294A3 Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage |
| 04/27/2006 | WO2005019435A8 Anti-cancer vaccines |
| 04/27/2006 | WO2005010150A3 Method for in vitro selection of 2’-substituted nucleic acids |
| 04/27/2006 | WO2005005601A3 Compositions and methods for treating and diagnosing cancer |
| 04/27/2006 | WO2004108898A3 Transfection agents |
| 04/27/2006 | WO2004094592A3 Polymer-conjugated glycosylated neublastin |
| 04/26/2006 | EP1649065A2 Methods for amplifying polymeric nucleic acids |
| 04/26/2006 | EP1649061A2 Genes as diagnostic tools for autism |
| 04/26/2006 | EP1649053A2 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 04/26/2006 | EP1649030A2 Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation |
| 04/26/2006 | EP1649025A2 Methods of decoupling reaction scale and protein synthesis yield in batch mode |
| 04/26/2006 | EP1649010A2 Novel nucleic acids from sesame plants |
| 04/26/2006 | EP1649007A2 Methods for ex-vivo expanding stem/progenitor cells |
| 04/26/2006 | EP1649005A2 P450 oxygenases and methods of use |
| 04/26/2006 | EP1649004A2 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |